FIELD: medicine, hematology.
SUBSTANCE: one should detect the quantity of human CD20+ B-lymphocytes in patient's blood due to immunofluorescence assay by applying monoclonal antibodies and at the level of CD20+ cells ranged 0.4 -7.0 x 109/l one should predict nonprogressing flow of chronic lympholeukosis, and at the level of CD20+ cells being above 7.0 x 109/l - progressing flow.
EFFECT: higher efficiency of prediction.
1 dwg, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE COURSE OF CHRONIC LYMPHOCYTIC LEUKEMIA | 2022 |
|
RU2788816C1 |
| METHOD FOR PREDICTION OF CLINICAL FORM OF CHRONIC LYMPHOLEUKAEMIA | 2012 |
|
RU2490642C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT AND FLOW OF CHRONIC LYMPHOLEUKOSIS | 2003 |
|
RU2248574C1 |
| METHOD FOR PREDICTION OF SMOULDERING FORM OF CHRONIC LYMPHOLEUKAEMIA | 2012 |
|
RU2496110C1 |
| METHOD FOR DETERMINING CLINICAL EFFECTIVENESS IN B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA | 2013 |
|
RU2548766C1 |
| METHOD OF SPECIFYING INDOLENT AND PROGRESSIVE FORMS OF STAGE A CHRONIC LYMPHOLEUKAEMIA | 2012 |
|
RU2490639C1 |
| METHOD FOR PROGNOSIS OF PROGRESSING CHRONIC LYMPHOLEUKOSIS BY QUANTITATIVE CONTENT OF NUCLEOLUS PROTEIN B23/NUCLEOFOZMINE IN LYMPHOID CELL LYSATES | 2005 |
|
RU2310201C2 |
| METHOD OF PREDICTING COURSE OF CHRONIC LYMPHOLUEKEMIA | 2009 |
|
RU2400753C1 |
| METHOD FOR DETECTION OF SURROGATE MARKERS OF MUTATIONS OF GENES OF VARIABLE REGIONS OF HEAVY CHAINS OF IMMUNOGLOBULINS IN CHRONIC LYMPHOCYTIC LEUKEMIA | 2023 |
|
RU2824086C1 |
| METHOD OF PREDICTING OVERALL SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA AT STAGE A | 2014 |
|
RU2565453C1 |
